5-Grass SLIT Shows Benefit in Allergic Rhinoconjunctivitis
Five-grass-pollen liquid sublingual immunotherapy (SLIT) reduced symptoms and the need for medications to treat symptoms in patients with allergic rhinoconjunctivitis (ARC) with or without asthma — while maintaining a favorable safety profile and providing consistent benefits across ages, comorbidities, and treatment durations.
METHODOLOGY:
Researchers conducted a systematic review and meta-analysis to evaluate the efficacy of five-grass-pollen liquid SLIT in patients with ARC with or without asthma.
Nine studies comparing the efficacy of interventional immunotherapy with that of placebo in this population were included.
The key outcomes comprised symptom severity, assessed as the symptom score; a reduction in medication use, assessed as the medication score; and the incidence of adverse events (AEs).
TAKEAWAY:
A pooled analysis of eight studies showed a significant reduction in symptom score in the interventional immunotherapy group vs the placebo group (standardized mean difference [SMD], -0.34; 95% CI, -0.62 to -0.06; P < .05) over a mean follow-up of 19 months.
Analysis of data pooled from six studies showed a significant reduction in use of drugs for symptoms in the interventional immunotherapy group vs the placebo group (SMD, -0.54; 95% CI, -0.97 to -0.10; P < .05) over a mean follow-up of 20 months.
AEs occurred in 20.6% of participants in the interventional immunotherapy group vs 17.5% in the placebo group (P = .46), with treatment discontinuation rates due to AEs of 3.0% and 1.8%, respectively (P = .41).
Treatment efficacy remained consistent regardless of cumulative dose, treatment duration, or asthma status.
IN PRACTICE:
'[The findings] suggest that the dose of five-grass SLIT-liquid can be safely adjusted for better adverse event management without compromising treatment outcomes,' the authors of the study wrote. 'This flexibility makes it possible to tailor treatment according to the patient's condition while addressing their needs and expectations,' they added.
SOURCE:
Danilo Di Bona, with the University of Foggia, Foggia, Italy, was the corresponding author of the study, which was published online on July 17 in the Journal of Investigational Allergology and Clinical Immunology.
LIMITATIONS:
The analysis had a relatively small sample size, variation in dosages and treatment durations across studies, and incomplete reporting of AEs in some studies.
DISCLOSURES:
This study was funded by Stallergenes Greer, a pharmaceutical company. One author declared receiving fees from this company. Some authors reported receiving consulting fees; payments or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events; or support for attending meetings or travel and serving on data safety monitoring boards or advisory boards for various pharmaceutical companies.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
A black goo was oozing from a ship on the Great Lakes — and teeming with life
Research vessel Blue Heron trawls the Great Lakes, gathering data from the water. The floating laboratory's most recent discovery, however, came from an unexpected location: its own rudder. While docked after a long cruise to study algae blooms in lakes Erie and Superior in September, the crew noticed a black, tar-like substance oozing from the rudder shaft, the mechanism that allows the 87-foot-long (nearly 27-meter-long) boat to change directions. Unsure of what the odd goo was, Doug Ricketts, marine superintendent and senior research associate at the University of Minnesota Duluth's Large Lakes Observatory, brought a cup of the substance to the observatory's scientists for testing. The scientists were surprised to find that the material was teeming with life-forms, some of which were unknown microorganisms. The mysterious substance, now informally named 'ShipGoo001,' had seemingly been thriving in the oxygen-free environment of the rudder shaft, according to a June 27 university announcement. 'There's no reason to expect any living organisms to be in this part of the ship,' Ricketts said, referring to the closed-off rudder shaft housing. 'This particular piece of a ship doesn't really move a lot. It's not exposed to the rest of the world.' If more goo is found, the goal will be to collect it without disturbing its oxygen-free environment, said lead researcher Cody Sheik, a microbial ecologist at Large Lakes Observatory. More careful study could lead to further discovery of new species of microbes, he added. 'One of the things that's fun about this, is that it was very unexpected. … All of these different things that we make become new habitats that (could be) right for microorganisms,' Sheik said. 'It makes me wonder: What else are we missing by not going out and just looking at something?' Studying the mysterious goo While some of the DNA extracted from the black goo was found to be from previously unknown microorganisms, other genetic material in the sample has been observed across the world. When researchers searched global databases, they discovered some DNA was related to microbes from a tarball-type substance in the Mediterranean, a hydrocarbon-contaminated sediment in Calgary, Alberta, and other samples from the coast of California to Germany. 'It's kind of all over the board in terms of what sort of environments these things are being found in,' Sheik said. 'I think we'll get a better idea of what these organisms are capable of by thinking more broadly about the other environments that they're found in.' The researchers still have many unanswered questions about the odd material, including how it came to be on the ship and whether it is capable of biocorrosion — eating or degrading the ship's steel. Since the substance was in its own sealed environment, it would need a complex food web to be able to thrive and sustain itself. '(Biocorrosion) is one of the things we have to worry about in oil pipelines and all these other really key infrastructure places. And so, you know, for some of these ships, especially the ones that are really long-lived here on the Great Lakes, because they're in fresh water, is this something where they could be corroding this area? It may be something to think about for future iterations of shipbuilding and things like that,' Sheik said. Researchers hope to answer these questions in a forthcoming research paper, which will also include the full genomes of the goo's microorganisms so other scientists can build on their work, Sheik added. Depending on what the researchers find, the material could have practical applications; methane-producing organisms in the substance could have potential use in biofuel production, according to the university's announcement. For now, researchers are keeping an eye out for more of the substance in the ship, and on other vessels, so they can gather additional samples and run further tests. The origin of the goo Because there are so many microbial species in the world — potentially up to 1 trillion — finding a new one isn't particularly surprising, said Jeffrey Marlow, an assistant professor of biology at Boston University. 'It's all about where they're found and what their genomic history or metabolic capacity is — that's what often makes a new species particularly exciting,' he added in an email. To ascertain the origin of the substance, Sheik and his team are putting together a history of the ship, as the former fishing boat was purchased pre-owned nearly three decades ago by the University of Minnesota Duluth. While the ship's rudder is not meant to be lubricated with anything other than water, it's possible that the previous owners oiled that area and those organisms laid dormant for years. What's more, the goo was not present during the ship's last inspection in November 2021. Marlow, who was not involved in the discovery, hypothesized that the ooze could have wound up in the rudder shaft by catching a ride on marine snow — clumps of dead organic matter that sink through the water column and contain oxygen-free pockets, he explained. Sheik plans to explore the goo's origin, noting that there are many scenarios to consider, including whether the substance grew in the rudder shaft in the first place or somehow hitched a ride on the boat. 'One of the coolest parts of this story is the fact that the sample made it to the microbiologists in the first place — it speaks to a 'microbiologically literate' culture where several people had the awareness and curiosity to ask what might be living in an otherwise inconvenient ooze,' Marlow said. 'It makes you wonder what other fascinating microbes could be living around us in the most unexpected places.' Taylor Nicioli is a freelance journalist based in New York. Sign up for CNN's Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. Solve the daily Crossword
Yahoo
4 hours ago
- Yahoo
Meta chief AI scientist Yann LeCun says Elon Musk risks 'killing breakthrough innovation' at xAI. Here's why.
Meta's Yann LeCun disagrees with Elon Musk about the role of researchers at AI companies. Musk earlier said xAI is ditching the "researcher" job title in favor of "engineers." LeCun said ignoring the distinction between them could risk "killing breakthrough innovation." Meta's chief AI scientist, Yann LeCun, doesn't agree with Elon Musk's latest take on AI development. Like, at all. Musk sparked a conversation about the roles of researchers and engineers at tech companies on Tuesday in an X post. Musk said his AI startup, xAI, would ditch the "researcher" job title in favor of "engineer." "This false nomenclature of 'researcher' and 'engineer', which is a thinly-masked way of describing a two-tier engineering system, is being deleted from @xAI today," Musk said. "There are only engineers. Researcher is a relic term from academia." Two days later, LeCun shared a screenshot of Musk's X post on LinkedIn with a multi-paragraph response. "If you make no distinction between the two activities, if you don't evaluate researchers and engineers with different criteria, you run the risk of killing breakthrough innovation," LeCun said. "True breakthroughs require teams with a long horizon and minimal constraints from product development and management." Musk isn't the first person to question the distinction between AI researchers and engineers. Other leading AI companies have, too. In a 2023 X post, OpenAI President Greg Brockman said that the company didn't want to put its workers into such defined buckets. Instead, the ChatGPT-maker settled on the phrase "Member of Technical Staff." Anthropic, which makes Claude, also uses "Member of Technical Staff" as a job title. "While there's historically been a division between engineering and research in machine learning, we think that boundary has dissolved with the advent of large models," Anthropic says on its careers page. LeCun, however, says the research labs that shaped what the science and tech industries have become were all separate from engineering divisions. "The industry research labs of yore that have left an indelible mark on scientific and technological progress (Bell Labs Area 11, IBM Research, Xerox PARC, etc) were all research divisions that were clearly separate from engineering divisions," LeCun said. Read the original article on Business Insider
Yahoo
4 hours ago
- Yahoo
Study reveals the foods which help avoid illness in later life
What you eat could determine how many chronic illnesses you get later in life, scientists warn. Research has revealed that a healthy diet - such as the Mediterranean diet which is high in plants, fish and unsaturated fats - could slow down the accumulation of chronic diseases including dementia in older adults. Inflammatory diets full of processed meat and sugar may accelerate it. Researchers from Karolinska Institutet in Sweden studied four diets to investigate their impact on chronic diseases in older adults. Three of the diets studied were healthy and focused on the intake of vegetables, fruit, whole grains, nuts, legumes, unsaturated fats and reduced intake of sweets, red meat, processed meat and butter/margarine. The fourth diet, however, was pro-inflammatory and focused on red and processed meat, refined grains and sweetened beverages, with lower intake of vegetables, tea and coffee. Researchers followed the diets of 2,400 adults aged 60 and older in Sweden for 15 years and tracked their chronic conditions. Dietary intake was measured using food frequency questionnaires, and adherence to four dietary patterns: the Empirical Dietary Inflammatory Index (EDII), AHEI, the Alternate Mediterranean Diet (AMED), and the MIND (Mediterranean–DASH Intervention for Neurodegenerative Delay). Multimorbidity was defined as the number of chronic diseases and grouped by organ system - musculoskeletal, cardiovascular, and neuropsychiatric. The results published in the journal Nature Aging revealed those who followed the healthy diets had a slower development of chronic diseases. For example, long-term adherence to healthy dietary patterns, particularly the AMED, AHEI, and MIND, was linked to a slower accumulation of chronic diseases in older adults. This applied to cardiovascular disease and dementia, but not to diseases related to muscles and bones. But those who followed the pro-inflammatory diet, on the other hand, increased their risk of chronic diseases. 'Our results show how important diet is in influencing the development of multimorbidity in ageing populations,' said co-first author Adrián Carballo-Casla, postdoctoral researcher at the Aging Research Centre, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet. The protective effects of diet may be explained by reduced inflammation, a key factor in aging-related diseases. Study authors want to further their research by identify the dietary recommendations that may have the greatest impact on longevity and the groups of older adults who may benefit most from them, based on their age, gender, psychosocial background and chronic diseases.
